Altaris LLC

Altaris LLC (formerly Altaris Capital Partners, LLC) is a private equity firm focused exclusively on the healthcare industry, investing across all major subsectors of healthcare in the United States. The firm targets companies in life sciences and pharmaceuticals, medical devices and medical technology, diagnostics, biotechnology, digital health, health information technology, contract manufacturing, healthcare services, and healthcare infrastructure, committing equity of $75 million to $750 million per transaction through its flagship fund vehicles, with flexibility to invest in both control and minority equity positions in public and private companies. Transaction types include leveraged buyouts, going-private transactions, growth equity investments, recapitalizations, and structured minority investments, with a consistent focus on businesses delivering value to the healthcare system through innovation, operational efficiency, or differentiated service delivery. Altaris applies an active, partnership-oriented ownership model built around close collaboration with management teams and alignment of interests across investors, operators, and clinical stakeholders, supported by sector-specialist investment professionals with backgrounds spanning private equity, investment banking, management consulting, and clinical practice. The firm manages approximately $10 billion in assets and has completed more than 136 investments and 40 exits since inception, with its current portfolio of companies employing approximately 7,500 people across its platform investments. The firm constructs focused portfolios of eight to twelve platform investments per fund, with its most recent flagship vehicle, Altaris Health Partners VI, targeting platform equity checks of $75 million to $750 million. Founded in 2003 by George Aitken-Davies and Daniel Tully, the firm is headquartered in New York, New York, United States.